CSTL
Castle Biosciences Inc
Price:  
29.48 
USD
Volume:  
386,278.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CSTL WACC - Weighted Average Cost of Capital

The WACC of Castle Biosciences Inc (CSTL) is 7.2%.

The Cost of Equity of Castle Biosciences Inc (CSTL) is 7.25%.
The Cost of Debt of Castle Biosciences Inc (CSTL) is 7.00%.

Range Selected
Cost of equity 6.30% - 8.20% 7.25%
Tax rate 1.50% - 2.20% 1.85%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.3% - 8.2% 7.2%
WACC

CSTL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.52 0.6
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 8.20%
Tax rate 1.50% 2.20%
Debt/Equity ratio 0 0
Cost of debt 7.00% 7.00%
After-tax WACC 6.3% 8.2%
Selected WACC 7.2%